Jane Street »

Dianthus Therapeutics shares owned by Jane Street

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Jane Street

Quarter filed Position value Share count Share price at filing
2024-09-30 $556k 20k 27.38
2024-03-31 $2.5M 82k 30.00
2023-12-31 $163k 16k 10.40

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Put Option (MSFT)
Amazon Call Option (AMZN)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Spdr Gold Tr Gold Shs (GLD)
Advanced Micro Devices Call Option (AMD)
Pdd Holdings Sponsored Ads Put Option (PDD)
Broadcom Put Option (AVGO)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Jane Street

Top funds holding Dianthus Therapeutics

Bain Capital Life Sciences Investors
Avidity Partners Management
Fairmount Funds Management
RA Capital Management
Octagon Capital Advisors
VR Adviser
BlackRock
BlackRock
Vanguard Group
5AM Venture Management
Henderson Group
Braidwell
Geode Capital Management
Point72 Asset Management
State Street Corporation

View all funds holding Dianthus Therapeutics